KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Intangibles (2016 - 2022)

TherapeuticsMD (TXMD) has disclosed Change in Intangibles for 11 consecutive years, with $95000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Change in Intangibles fell 93.73% year-over-year to $95000.0, compared with a TTM value of $355000.0 through Dec 2022, down 83.78%, and an annual FY2022 reading of $355000.0, down 83.78% over the prior year.
  • Change in Intangibles was $95000.0 for Q4 2022 at TherapeuticsMD, up from -$7000.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $1.5 million in Q4 2021 and bottomed at -$7000.0 in Q3 2022.
  • Average Change in Intangibles over 5 years is $324120.4, with a median of $309762.0 recorded in 2018.
  • The sharpest move saw Change in Intangibles soared 364.42% in 2021, then tumbled 102.78% in 2022.
  • Year by year, Change in Intangibles stood at $356501.0 in 2018, then increased by 4.76% to $373458.0 in 2019, then decreased by 12.71% to $326000.0 in 2020, then skyrocketed by 364.42% to $1.5 million in 2021, then crashed by 93.73% to $95000.0 in 2022.
  • Business Quant data shows Change in Intangibles for TXMD at $95000.0 in Q4 2022, -$7000.0 in Q3 2022, and $97000.0 in Q2 2022.